These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 9270593
1. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Tennis P, Stern RS. Neurology; 1997 Aug; 49(2):542-6. PubMed ID: 9270593 [Abstract] [Full Text] [Related]
2. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Neurology; 2005 Apr 12; 64(7):1134-8. PubMed ID: 15824335 [Abstract] [Full Text] [Related]
3. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders. Otoom S, Bakhiet M, Khan A, Sequeira R. Neuro Endocrinol Lett; 2006 Apr 12; 27(1-2):85-8. PubMed ID: 16648782 [Abstract] [Full Text] [Related]
4. Anticonvulsant drug hypersensitivity. Galindo PA, Borja J, Gómez E, Mur P, Gudín M, García R, Encinas C, Romero G, Garrido JA, Cortina P, Feo F. J Investig Allergol Clin Immunol; 2002 Apr 12; 12(4):299-304. PubMed ID: 12926190 [Abstract] [Full Text] [Related]
5. Hepatic considerations in the use of antiepileptic drugs. Dreifuss FE, Langer DH. Epilepsia; 1987 Apr 12; 28 Suppl 2():S23-9. PubMed ID: 3121292 [Abstract] [Full Text] [Related]
7. Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate. Duncan JS, Shorvon SD, Trimble MR. J Neurol Neurosurg Psychiatry; 1988 Jul 12; 51(7):924-8. PubMed ID: 3144581 [Abstract] [Full Text] [Related]
8. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin]. Pita-Calandre E, Rodríguez-López CM, Cano MD, Peña-Bernal M. Rev Neurol; 1998 Nov 12; 27(159):785-9. PubMed ID: 9859151 [Abstract] [Full Text] [Related]
9. Anticonvulsant effects on the memory performance of epileptics. Butlin AT, Danta G, Cook ML. Clin Exp Neurol; 1984 Nov 12; 20():27-35. PubMed ID: 6439447 [Abstract] [Full Text] [Related]
10. Quantifying the costs of serious adverse drug reactions to antiepileptic drugs. Schlienger RG, Oh PI, Knowles SR, Shear NH. Epilepsia; 1998 Nov 12; 39 Suppl 7():S27-32. PubMed ID: 9798759 [Abstract] [Full Text] [Related]
12. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study. Gau SS, Chao PF, Lin YJ, Chang CJ, Gau CS. J Clin Psychopharmacol; 2008 Oct 12; 28(5):509-17. PubMed ID: 18794645 [Abstract] [Full Text] [Related]
13. Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial. Berg I, Butler A, Ellis M, Foster J. Dev Med Child Neurol; 1993 Feb 12; 35(2):149-57. PubMed ID: 8444328 [Abstract] [Full Text] [Related]
17. Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine. Cogrel O, Beylot-Barry M, Vergier B, Dubus P, Doutre MS, Merlio JP, Beylot C. Br J Dermatol; 2001 Jun 12; 144(6):1235-8. PubMed ID: 11422049 [Abstract] [Full Text] [Related]
18. Anticonvulsant hypersensitivity syndrome: report of 2 cases from Kuwait. Bin-Nakhi HA, Sadeq S, Pinto RG, Habeeb Y. Med Princ Pract; 2003 Jun 12; 12(3):197-9. PubMed ID: 12766341 [Abstract] [Full Text] [Related]